Xcout Intel
Johnson & Johnson competitors & alternatives
The 12 closest competitors and alternatives to Johnson & Johnson among pharmaceuticals companies — ranked by similarity to what Johnson & Johnson actually does, not by market-cap band.
Subscribe to see Johnson & Johnson’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Johnson & Johnson
The Toronto office of Johnson & Johnson is a corporate location situated in the Greater Toronto Area in cities such as Markham and Guelph, Ontario, Canada. It serves as a physical workplace for employees supporting the healthcare company's regional operations.
Johnson & Johnson at a glance
Johnson & Johnson is a pharmaceuticals company headquartered in New Brunswick, United States. It is publicly listed (JNJ) with a market capitalisation of $653.6B. Xcout tracks 23 named people at Johnson & Johnson, including Joaquin Duato (Chief Executive Officer & Chairman). Xcout recorded 22 job postings from Johnson & Johnson in the last 90 days.
Johnson & Johnson leadership
- Joaquin DuatoChief Executive Officer & Chairman
- Joseph J. WolkExecutive Vice President & Chief Financial Officer
- Kristen Blair MulhollandExecutive Vice President & Chief Human Resources Officer
- Dirk BrinckmanChief Compliance Officer
- Elizabeth ForminardExecutive Vice President & Chief Legal Officer
- James SwansonExecutive Vice President & Chief Information Officer
17 more named people on record for Johnson & Johnson, with roles, board committees and tenure — see the full roster →
Hiring at Johnson & Johnson
Xcout recorded 22 job postings from Johnson & Johnson in the last 90 days, from a hiring record Xcout has kept since May 2026.
The weekly hiring trend, the roles and locations behind it — see Johnson & Johnson's hiring signals →
Recent Johnson & Johnson news
- AcquisitionThe Manufacturers Life Insurance Company Acquires 180,724 Shares of Johnson & Johnson $JNJ - InsuranceNewsNet
- AcquisitionJ&J orthopedics unit draws Apollo interest in potential $20 billion deal, Bloomberg News reports
- AcquisitionJ&J orthopedics unit draws Apollo interest in potential $20 billion deal, Bloomberg News reports - Reuters
- AcquisitionEmpresa sueca compra dona de Sempre Livre, Carefree e O.B. no Brasil por R$ 1,47 bilhão - O GLOBO
9 corporate events on record, with sources — see the full timeline →
Top 12 Johnson & Johnson competitors
Ranked by semantic similarity — how close each company is to Johnson & Johnson by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar pharmaceuticals company
Bausch Health Companies Inc., together with its associated entities, is engaged in the development, manufacturing, and commercialization of a diverse portfolio of pharmaceutical products, medical devices, and over-the-counter remedies. Its primary therapeutic focus areas include ophthalmology, digestive health, and dermatology. The enterprise conducts its operations through five principal divisions: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment is dedicated to vision care, encompassing surgical instruments, consumer eye health products, and ophthalmic pharmaceuticals. Salix specializes in delivering gastroenterology-specific products exclusively within the United States. The International Rx division markets Solta products, a range of branded and generic pharmaceuticals, OTC items, medical devices, and Bausch + Lomb offerings across diverse geographies including Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. Ortho Dermatologics focuses on dermatological products in the U.S., in addition to distributing Solta's medical aesthetic devices globally. Finally, the Diversified Products segment supplies pharmaceutical solutions for neurology and other therapeutic categories, as well as generic medications and dental products, all within the U.S. The company was formerly known as Valeant Pharmaceuticals International, Inc., officially changing its name to Bausch Health Companies Inc. in July 2018. Its corporate headquarters are located in Laval, Canada.
Healthcare
Bausch & Lomb is a major Canadian eye health products company based in Vaughan, Ontario. The firm operates globally as one of the world's largest suppliers of contact lenses, intraocular lenses, and comprehensive eye care pharmaceuticals.
Similar pharmaceuticals company
JAMP Pharma Group is a private Canadian pharmaceutical company launched in 1988 and based in the Montreal region of Quebec. Originally operating as a contract manufacturing organization, the company now actively supplies a broad range of pharmaceutical products across Canada.
Biotechnology, Pharmaceuticals
Sanofi Pasteur Ltd. is a pharmaceutical manufacturing company headquartered in Ontario, Canada. It is part of Sanofi, a global pharmaceutical company focused on shaping healthcare with innovative solutions and treatments.
Similar pharmaceuticals company
The Janssen Pharmaceutical Companies are part of Johnson & Johnson, focusing on innovative medicine. They were founded as pharmaceutical companies and have a history of developing new treatments.
Similar pharmaceuticals company
Daiichi Sankyo Co., Ltd. is a global pharmaceutical company with a strong legacy of innovation. The company maintains a robust pipeline of medicines and has a presence in various countries, including Canada and the US.
Similar pharmaceuticals company
Astellas Pharma Inc. is a Japanese pharmaceutical company headquartered in Tokyo. The company has global offices and research centers.
Similar pharmaceuticals company
Medexus Pharmaceuticals Inc. operates as a pharmaceutical company in Canada and the United States. The company focuses on various therapeutic areas comprising allergy, dermatology, hematology, oncology, rheumatology, and rare diseases. Its primary products include IXINITY, an intravenous recombinant factor IX therapeutic for use in patients with hemophilia B; Rasuvo and Metoject, a formulation of methotrexate designed to treat rheumatoid arthritis and other auto-immune diseases; Rupall, a prescription allergy medication; GRAFAPEX, an injection to treat allogeneic hematopoietic stem cell transplantation in adult and pediatric patients, acute myeloid leukemia (AML), and myelodysplastic syndrome (MDS); and Gleolan, an optical imaging agent for patients with glioma as an adjunct for the visualization of malignant tissue during surgery. The company’s products portfolio also includes Cuvposa, a glycopyrrolate oral solution; Naproxen, a Pediapharm naproxen suspension; Otixal, a ciprofloxacin and flucinolone acetonide; Trispan, a triamcinolone hexacetonide injectable suspension; and Trecondyv, a bifunctional alkylating agent for use as part of a conditioning treatment for patients undergoing allogeneic hematopoietic stem cell transplantation. In addition, it offers over the counter products comprising Nyda, a topical treatment indicated for the eradication of head lice; Relaxa, an osmotic laxative to treat occasional constipation in adults; Oralvisc to reduce joint pain and enhance joint function in osteoarthritis of the knee; and Calcia Calcium and vitamin D products. The company was formerly known as Pediapharm Inc. and changed its name to Medexus Pharmaceuticals Inc. in December 2018. Medexus Pharmaceuticals Inc. was founded in 2000 and is based in Toronto, Canada.
Similar pharmaceuticals company
GSK is a biopharmaceutical company that discovers, develops, and delivers medicines and vaccines for patients globally. Its research and development efforts focus on four primary therapeutic areas: respiratory, immunology and inflammation, oncology, HIV, and infectious diseases.
Biotech
Deep Genomics is a biotechnology research company that collaborates across disciplines to solve complex molecular design challenges. The company's corporate headquarters are located in Toronto, Ontario, Canada, a hub for innovation.
Biotechnology
Ambrx Biopharma was a biotechnology company that developed antibody-drug conjugates and other engineered protein therapeutics using its expanded genetic code and site-specific conjugation technologies. Its programs targeted cancer and were developed for pharmaceutical and healthcare markets; Johnson & Johnson acquired the company in 2024.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Johnson & Johnson and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Johnson & Johnsonand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →